From an article by Jon Markman at thestreet.com:
Using data, machine learning and AI, Alphabet managers are incubating vibrant new businesses in pharma and tech. One or more of these will become exciting stand-alone businesses.
This might seem a particularly bad time to be investing in big tech.
President Trump said Tuesday morning that his administration would look into accusations that Google has been secretly working with the Chinese military. The charge came from Peter Thiel, a PayPal (PYPL – Get Report) co-founder and strong supporter of the president.
On the other hand, Bloomberg reported Tuesday that DeepMind, the artificial-intelligence arm of Alphabet, (GOOGL – Get Report) might be on the cusp of a major breakthrough in the way new drugs are discovered.
It’s an important innovation. It’s hiding inside the search giant. And it couldn’t come at a better time.
This business is on to something really big. Using data, machine learning and AI, Alphabet managers are incubating vibrant new businesses with innovative business models. One or more of these will become exciting stand-alone businesses.
Some analysts are already doing sum-of-the-parts analyses and they like what they see.
A Jefferies analyst pegged the value of Waymo, Alphabet’s self-driving-car business, at $250 billion in December 2018, according to a story at Business Insider.
Alphabet’s market capitalization is $798 billion, with units including YouTube, Google Search, Google Cloud, Android, the Nest security camera and peripheral businesses, Google Capital, and Stadia, its new video game streaming service set to launch in November.
Together, these parts are probably worth well over $1 trillion.
Until now, the business opportunity for DeepMind was not even on investors’ radar.
The subsidiary has its roots in DeepMind Technologies, a British AI startup that was making progress teaching computers the quirks of human short-term memory. Alphabet acquired the business in 2014.
Two years later, its custom AlphaGo code was so advanced that it became the first computer program to defeat a human in a match of Go, the ancient Chinese strategy game. That human happened to be Lee Sedol, the 18-time world champion.
At the CASP13 meeting in Mexico in December 2018, DeepMind was at it again. This time its human challengers were the brightest minds in biology. The task was predicting the shapes of proteins.
Understanding these structures is important because they govern how diseases form. The problem is there are more possible protein shapes than there are atoms in the universe, Bloomberg notes.
The math has vexed computational biologists for the past 25 years. They have been trying to build more predictive software models for protein folding, the process that leads to proteins taking three-dimensional shapes.
Despite its limited experience with folding, AlphaFold, DeepMind’s entrant, predicted the most accurate structure for 25 out of 43 proteins, taking the top spot over 98 participating teams, according to a report in the Guardian.
Image Credit: Google AI
News This Week
Severe Covid-19 illness in young possibly down to genes or ‘viral load’, scientists say
Coronavirus hits the old and those with other health problems hardest, but fit, youthful people are dying too, and experts are trying to understand why: It remains one of the biggest puzzles of the [...]
The race to find a coronavirus treatment has one major obstacle: Big Pharma
he past few weeks have revealed the worst and the best in human responses to the coronavirus crisis – from the supermarket hoarders clearing the shelves to the neighbourhood groups organising help for elderly [...]
Oxford firm to screen 15,000 drugs in search for coronavirus cure
An Oxford-based firm that uses artificial intelligence to develop new medicines has teamed up with a UK national science facility to screen more than 15,000 drugs for their effectiveness as a treatment for Covid-19. [...]
New study sheds light on coronavirus infection mechanism
New research has shed light on a crucial biological mechanism that may have helped the coronavirus to infect humans and spread rapidly around the world. A detailed analysis of the virus’s structure shows that [...]
Comparing the coronavirus pandemic to past pathogenic threats: HIV, anthrax and Ebola
How does the COVID-19 pandemic compare to other infamous viral infections that have plagued us in modern times? It’s a question that’s been asked repeatedly in social media circles in recent weeks as people [...]
Nanoparticles could help us get closer to a treatment for COVID-19
There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. Since the outbreak began in late 2019, researchers have been racing to [...]
Corona Virus (COVID 19) Interview with Michael Osterholm an expert in infectious disease epidemiology.
Michael Osterholm is an internationally recognized expert in infectious disease epidemiology. He is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the director of the Center for Infectious Disease Research and Policy [...]
Experts envision two scenarios if the new coronavirus isn’t contained
With the new coronavirus spreading from person to person (possibly including from people without symptoms), reaching four continents, and traveling faster than SARS, driving it out of existence is looking increasingly unlikely. It’s still [...]
Neural cells speed up function in 3D bioprinted skeletal muscle constructs
Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have improved upon the 3D bioprinting technique they developed to engineer skeletal muscle as a potential therapy for replacing diseased or damaged muscle tissue, moving another [...]
Scientists Use a “Synaptor” to Link a Rat Neuron and a Silicon Neuron
An international team of scientists from the University of Southampton, the University of Padova, and the University of Zurich has connected a silicon neuron to a neuron from the rat hippocampus with an artificial [...]
The Ins & Outs of Gene Therapy Drug Development: an interview with NMIN’s Scientific Director
In an insightful 42-minute interview, NMIN’s Scientific Director Dr. Pieter Cullis, a pioneer in liposomal gene and drug delivery, discusses his scientific career with a focus on his contributions to the evolution of [...]
Powerful antibiotic discovered using machine learning for first time
A powerful antibiotic that kills some of the most dangerous drug-resistant bacteria in the world has been discovered using artificial intelligence. The drug works in a different way to existing antibacterials and is the [...]
“Bigger than DNA” — how AI is transforming the pharma industry
Artificial intelligence hit a big milestone in January — the first drug designed entirely using artificial intelligence entered human clinical trials. The compound, created by Oxford-based biotech company Exscientia, is aimed at treating obsessive-compulsive [...]
Achilles’ heel of ALL viruses? Scientists discover holy grail which could lead to UNIVERSAL vaccine
Researchers at the Massachusetts General Hospital (MGH) in the US have uncovered the ‘Achilles’ heel’ of most viruses which plague mankind, and could soon develop a universal vaccine. Vaccine research, development and testing takes [...]
Small world: atom-scale materials are the next tech frontier
Every age in the history of human civilisation has a signature material, from the Stone Age, to the Bronze and Iron Ages. We might even call today’s information-driven society the Silicon Age. Since the [...]
Human textiles to repair blood vessels
What if we could replace a patient's damaged blood vessels with brand new ones produced in a laboratory? This is the challenge set by Inserm researcher Nicolas L'Heureux, who is working on the human [...]
Leave A Comment